Pfizer LLN 100 (Lorbrena 100 mg)
Generic Name: lorlatinib
Pill with imprint Pfizer LLN 100 is Purple, Elliptical / Oval and has been identified as Lorbrena 100 mg. It is supplied by Pfizer Inc..
Lorbrena is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. Lorbrena 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer LLN 100
Lorbrena
- Generic Name
- lorlatinib
- Imprint
- Pfizer LLN 100
- Strength
- 100 mg
- Color
- Purple
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0231
More about Lorbrena (lorlatinib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: multikinase inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.